Cafepharma Today

June 9 2025 - Merck claims study success with PCSK9 cholesterol pill
Merck claims study success with PCSK9 cholesterol pill
FDA limits Merck's Keytruda, Bristol Myers' Opdivo in stomach cancer
Drug imports plummeted in April despite tariff threat
Sanofi starts shipping RSV drug early as rival nears market
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck Third Quarter Earnings Preview
Investopedia.com
Tuesday, October 23, 2012 - 11:35am
tags:
Merck, earnings
How GlaxoSmithKline Has Fared During 2012
Motley Fool
Tuesday, October 23, 2012 - 11:31am
tags:
GSK
FDA approves Eisai's drug to treat epileptic seizures
Yahoo/Reuters
Tuesday, October 23, 2012 - 9:19am
tags:
FDA, Eisai, epilepsy, seizures, Fycompa
Roche continues to restructure diabetes unit
Indianapolis Business Journal, IN
Tuesday, October 23, 2012 - 9:17am
tags:
Roche, restructuring, diabetes, layoffs
Synergy Pharmaceuticals: Monday's Pipeline News Strengthens Company At Its Core
Seeking Alpha
Tuesday, October 23, 2012 - 9:15am
tags:
Synergy Pharmaceuticals, SP-333, ulcerative colitis
Novo Nordisk: Encouraging Pipeline News
Seeking Alpha
Tuesday, October 23, 2012 - 9:13am
tags:
Novo Nordisk, Tresiba, Ryzodeg, diabetes
Agenus commences Phase 2 study of HerpV vaccine for treatment of genital herpes
Yahoo/Fly the on Wall
Tuesday, October 23, 2012 - 9:10am
tags:
HerpV, vaccines, genital herpes, Agenus
Johnson & Johnson: Litigation Makes This Pharma A Pass In 2013
Seeking Alpha
Tuesday, October 23, 2012 - 9:09am
tags:
JNJ
Glaxo Fund Looks for Early-Stage Alzheimer’s Detectors
Bloomberg
Tuesday, October 23, 2012 - 9:08am
tags:
GSK, Alzheimer's disease
FDA Lightens Up on Obesity Drugs
Motley Fool
Monday, October 22, 2012 - 6:12pm
tags:
FDA, obesity, Contrave, Arena Pharmaceuticals, Vivus, Orexigen
Hormone replacement therapy not recommended for disease prevention-U.S. panel
Reuters
Monday, October 22, 2012 - 6:10pm
tags:
HRT, menopause, Pfizer
Astellas launches bladder drug, aiming for a $1.9B franchise
Fierce Pharma
Monday, October 22, 2012 - 12:11pm
tags:
Astellas, Myrbetriq, overactive bladder
Bayer lung drug shows promise in pulmonary hypertension
Reuters
Monday, October 22, 2012 - 12:09pm
tags:
Bayer, PAH, Actelion, Gilead, Riociguat, Tracleer
GlaxoSmithKline says five late-stage trials meet main goal
Reuters
Monday, October 22, 2012 - 12:07pm
tags:
GSK, vaccines, Flu, QIV
Will Dendreon Surprise The Street On October 30?
Seeking Alpha
Monday, October 22, 2012 - 11:52am
tags:
Dendreon, Provenge
Celgene Third Quarter Earnings Preview
Investopedia.com
Monday, October 22, 2012 - 11:43am
tags:
Celgene, earnings
Biogen Idec Third Quarter Earnings Preview
Investopedia.com
Monday, October 22, 2012 - 11:42am
tags:
earnings, Biogen Idec
Teva Phase IIa Laquinimod trail results show positive data for Chron's
Yahoo/Fly on the Wall
Monday, October 22, 2012 - 11:41am
tags:
Chron's Disease, laquinimod, Teva
Orexigen receives dispute response from FDA
The Fly on the Wall
Monday, October 22, 2012 - 11:37am
tags:
FDA, Orexigen, Contrave
Eli Lilly's Upcoming Earnings: What You Need To Know
Motley Fool
Monday, October 22, 2012 - 11:37am
tags:
earnings, Eli Lilly

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.